DalsnaFinance › IPOs › Maze Therapeutics Inc › IPO
Maze Therapeutics, Inc. completed its initial public offering on NASDAQ on January 31, 2025, pricing at $16.00 a share.
| Ticker | MAZE |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 31, 2025 |
| Offering price | $16.00 |
| Shares offered | 8,750,000 |
| Total raised | $140M |
Maze Therapeutics, Inc. sold 8,750,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $140 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $140 million total recorded for the deal.
Measured by money raised, Maze Therapeutics, Inc. was the 303rd largest of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is the 225th largest.
January 2025 saw 17 completed IPOs in the site's data; by amount raised, Maze Therapeutics, Inc. was the 12th largest of the 17 deals with a recorded size.
Its $16.00 offer price was tied for the 109th highest (level with 11 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Maze Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Maze Therapeutics, Inc.. This page is general information, not investment advice.